Funded Tech Companies
Arch Oncology
Headquartered in Brisbane, Arch Oncology has funding from Roche Venture Fund, Adage Capital Management and FMB Research.
Company Overview
Company Name
Arch Oncology
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2000 Sierra Point Pkwy. 700
Brisbane, CA 94005
USA
Brisbane, CA 94005
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Arch Oncology is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of best-in-class antibody therapies for the treatment of patients with cancer. Our next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative to other agents in this class.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/25/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laurence Blumberg
Chief Medical Officer
Jackie Walling
Chief Operating Officer
Ronald Krasnow
Chief Scientific Officer
Daniel Pereira
Vice President
Vicki Sung
VP - Finance
Galit Yaakobovitz
VP - Operations
Kevin Romanko
VP - R & D
Arun Kashyap
VP - Regulatory Affairs
Michele DeVries
Company Investors
- Roche Venture Fund
- Adage Capital Management
- FMB Research
- Avego Healthcare Capital
- 3x5 Partners (Joseph Biller)
- Lightchain
- Cowen Capital Partners (Eric Pham)
- Point72 Ventures
- RiverVest Venture Partners (John McKearn)
- Eventide Asset Management (Joy Ghosh)
- Broadfin Capital
- 3x5 Special Opportunity Partners
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs